OBIO
Orchestra BioMed Holdings Inc.
NASDAQ: OBIO · HEALTHCARE · BIOTECHNOLOGY
$3.80
-2.56% today
Updated 2026-04-29
Market cap
$239.94M
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$2 – $5
Volume
0.2M
Orchestra BioMed Holdings Inc. (OBIO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $38.09M | $13.53M | $95.57M | $95.21M | $76.17M |
| Cash & equivalents | $20.34M | $9.94M | $19.78M | $30.56M | $22.26M |
| Current assets | $36.25M | $11.32M | $84.69M | $89.11M | $69.17M |
| Total liabilities | $86.63M | $84.76M | $43.04M | $27.17M | $43.22M |
| Current liabilities | $14.36M | $12.24M | $18.57M | $11.21M | $16.21M |
| Long-term debt | $5.46M | $3.67M | $9.49M | — | $14.29M |
| Shareholder equity | $-48.54M | $-71.23M | $52.53M | $68.04M | $32.96M |
| Retained earnings | $-143.11M | $-166.13M | $-199.73M | $-248.85M | $-309.88M |
| Accounts receivable | $168000.00 | $121000.00 | $96000.00 | $99000.00 | $92000.00 |
| Inventory | $69000.00 | $68000.00 | $276000.00 | $146000.00 | $173000.00 |
| Goodwill | — | — | — | — | — |